Contract W81K0021P0235
Biomerieux Inc · Department Of Defense · August 1, 2024
Biomerieux Inc was awarded a federal contract by Department Of Defense (Department Of The Army) on August 1, 2024 for $108,000 of work in in-vitro diagnostic substance manufacturing. Performance is in Durham, NC. It was awarded under full and open competition. The contract has been modified 5 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on December 3, 2025. If all options are exercised, the contract could reach $970,000.
Contract details
- PIID
- W81K0021P0235
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Competed Under Sap
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product / service
- Medical And Surgical Instruments, Equipment, And Supplies
- Place of performance
- Durham, NC
- First action
- August 1, 2024
- Latest action
- December 3, 2025
Description
IN ACCORDANCE WITH FEDERAL ACQUISITION REGULATION (FAR) 52.232-18, AVAILABILITY OF FUNDS, FY26 FUNDS ARE AVAILABLE AND HEREBY OBLIGATED FOR PURCHASE ORDER W81K00-21-P-0235 FOR THE PERIOD OF 1 OCTOBER 2025 - 30 SEPTEMBER 2026.
Modification timeline
-
December 3, 2025Mod P00015 · Funding Only Action$851.9K
-
September 17, 2025Mod P00014 · Funding Only ActionTHE PURPOSE FOR THIS MODIFICATION IS TO DE-OBLIGATE EXCESS FY24 FUNDS, IN ORDER TO REFLECT ACTUAL AMOUNTS USED DURING PERFORMANCE OF THE CONTRACT IN FY24 (01 OCTOBER 2023 - 30 SEPTEMBER 2024.$1.46M
-
July 2, 2025Mod P00013 · Exercise An OptionPURSUANT TO FEDERAL ACQUISITION REGULATION (FAR) 52.217-9, OPTION TO EXTEND THE TERM OF THE CONTRACT, W81K00-21-P-0235 WITH BIOMERIEUX, INC. IS HEREBY EXTENDED FOR THE PERIOD 01 OCTOBER 2025 - 30 SEPT…$1.10M
-
September 20, 2024Mod P00010 · Funding Only ActionGN/AST GENERIC GN AST 20 CARDS/BOX$1.04M
-
September 16, 2024Mod P00009 · Exercise An OptionGN/AST GENERIC GN AST 20 CARDS/BOX$1.04M
-
August 1, 2024Mod P00008 · Supplemental Agreement For Work Within ScopeGN/AST GENERIC GN AST 20 CARDS/BOX - INCREASE & DECREASE IN QUANTITIES.$1.04M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Diasorin Inc | Department Of Defense | December 31, 2025 | $518.8K |
| Bloodworks | Department Of Defense | December 31, 2025 | $160.2K |
| Sl Meditech Co. | Department Of Defense | December 31, 2025 | $151.6K |
| Alba Bioscience, Inc. | Department Of Defense | December 31, 2025 | $163.2K |
| Werfen USA Llc | Department Of Defense | December 31, 2025 | $18.1K |
| Immucor Inc | Department Of Defense | December 31, 2025 | $154.2K |
Top contractors in NAICS 325413
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Biomerieux Inc | 182 | $25.50M |
| 2 | Cepheid | 114 | $20.70M |
| 3 | Roche Diagnostics Corporation | 125 | $13.00M |
| 4 | Quest Diagnostics Incorporated | 8 | $4.31M |
| 5 | Hologic Sales And Service, Llc | 39 | $3.88M |
| 6 | Beckman Coulter, Inc | 28 | $3.40M |
| 7 | Fisher Scientific Company L.L.C. | 52 | $3.04M |
| 8 | Werfen USA Llc | 91 | $2.75M |
| 9 | Diasorin Inc | 21 | $2.74M |
| 10 | Abbott Laboratories Inc. | 10 | $2.69M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract W81K0021P0235?
Contract W81K0021P0235 is a federal contract awarded to Biomerieux Inc by Department Of Defense on August 1, 2024 for $108,000 of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 5 times since the base award.
Who won contract W81K0021P0235?
Biomerieux Inc won contract W81K0021P0235 from Department Of Defense.
How much is contract W81K0021P0235 worth?
Contract W81K0021P0235 has obligated $108,000 to date, with a total potential value of $970,000 if all options are exercised.